Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 408-412, February 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Momparler, R. L.
Right arrow Articles by Rossi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Momparler, R. L.
Right arrow Articles by Rossi, M.

Enzymatic Estimation and Metabolism of 1-ß-D-Arabinofuranosylcytosine in Man1

Richard L. Momparler, Aurora Labitan and Mosé Rossi2

McGill University Cancer Research Unit, Montreal, Quebec, Canada

An enzymatic method for the estimation of the concentration of 1-ß-D-arabinofuranosylcytosine (ara-C) in biological fluid has been developed. The method consists of the phosphorylation of ara-C with ATP-{gamma}-32P in the presence of deoxycytidine kinase and Mg++ and subsequent isolation of the 5'-monophosphate of ara-C (ara-CMP-{alpha}-32P) by thin-layer chromatography on diethylaminoethyl-cellulose. This method requires only 3 hr to complete and can detect concentrations of ara-C in the plasma as low as 2.5 {varepsilon}M. With this enzymatic method the half-life of ara-C in the plasma was estimated to be 15 min in a patient with acute leukemia who received a continuous i.v. infusion of ara-C.

Since for most nucleoside analogs the active inhibitor is a phosphorylated derivative, the enzymatic method can be used as an additional procedure for the screening of potential antitumor nucleosides.

1 Supported by the National Cancer Institute of Canada.

2 Recipient of USPHS International Fellowship 1F05 TWO 1731-01. Present address: Laboratory of Molecular Embryology, Naples, Italy.

Received 9/28/71. Accepted 11/ 4/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.